– Enlivex has adopted the world’s first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation. – RAIN is a fully decentralized predictions and options protocol that redefines predictive market ecosystems and provides a powerful platform for on-chain market creation - built for transparency, automation, and community participation. – Mr. Matteo Renzi, former Prime Minister of Italy has joined the Enlivex Board of Directors. – Enlivex to continue clinical development of Al ...

Accessibility StatementSkip Navigation Enlivex Announced today $212,000,000 private placement to initiate world's first prediction markets digital asset treasury strategy, via RAIN token accumulation NESSÂ ZIONA, Israel, Nov. 24, 2025 /PRNewswire/ -- Enlivex Therapeutics Ltd. (NASDAQ: ENLV) today announced the appointment of Mr. Matteo Renzi, former Prime Minister of Italy, to the board of directors at Enlivex, effective November 24th. 2025. Continue Reading Mr. Matteo Renzi, former Prime Minister of Italy ...

Core Insights - Enlivex Therapeutics has entered into a private investment in public equity (PIPE) agreement to sell 212 million ordinary shares at $1.00 per share, raising approximately $212 million, which will be used to implement a RAIN prediction markets token treasury strategy [3][8][9] - The company will be the first publicly-listed entity to adopt a treasury strategy centered on the RAIN token, aiming to provide investors with exposure to the rapidly growing prediction markets sector [5][9] - Enlivex continues its focus on the clinical development of Allocetra™, a novel therapy for knee osteoarthritis, a condition affecting over 32.5 million Americans [10] Company Developments - The PIPE transaction represents a premium of 11.5% from the stock's closing price on November 21, 2025 [3][8] - Matteo Renzi, former Prime Minister of Italy, will join the Enlivex Board of Directors following the closing of the private placement [2] - The closing of the transaction is expected on or before November 25, 2025, pending customary closing conditions [5] Industry Context - The prediction markets industry is experiencing significant institutional interest, highlighted by a $2 billion investment by NYSE's parent company in Polymarket and a $300 million financing round for Kalshi led by prominent venture capital firms [5] - RAIN is a decentralized predictions and options protocol built on the Arbitrum network, allowing users to create and trade custom options on various markets [4] - The protocol features a deflationary Buyback & Burn mechanism and aims to be a leading platform in the prediction markets space, similar to Uniswap in decentralized finance [4]

Core Insights - Enlivex Therapeutics is set to implement a unique treasury strategy centered around the RAIN prediction markets token, marking it as the first publicly-listed company to do so in the U.S. [1][8] - The company is continuing the clinical development of Allocetra™, a therapy aimed at treating knee osteoarthritis, addressing a significant unmet medical need in a growing market [2][9] - The private placement transaction involves the sale of 212 million ordinary shares at $1.00 per share, yielding approximately $212 million in gross proceeds [3] Company Developments - Enlivex will appoint former Italian Prime Minister Matteo Renzi to its Board of Directors following the private placement [2] - The company plans to utilize the net proceeds from the PIPE transaction to implement the RAIN treasury strategy while maintaining focus on its core business operations [3][5] - The price per share for the private placement represents an 11.5% premium over the previous closing price [2] Industry Context - The prediction markets sector is experiencing significant institutional interest, highlighted by a $2 billion investment in Polymarket and a $300 million financing round for Kalshi [5] - RAIN is described as a fully decentralized predictions and options protocol, allowing users to create and trade custom options on various markets [4] - The market for osteoarthritis treatments is substantial, with over 32.5 million Americans affected and projections indicating that 78 million Americans may have osteoarthritis by 2040 [9]

Enlivex Therapeutics Ltd. (NASDAQ:ENLV) on Monday announced a private investment in public equity of 212 million shares at $1.00 per share, representing a premium of 11.5% from the closing price of the stock on November 21, 2025. The company expects gross proceeds of approximately $212 million (funded in a combination of $USD and USDT). Enlivex will use the proceeds from the PIPE to implement the first RAIN prediction markets token treasury strategy, while continuing its focus on the company's core busine ...

🔥RAIN @Rain__Protocol trading is now live on #BitMart!💰Trade now: https://t.co/M284Yb4bPr🎉Register Now: https://t.co/OvD9tAjZYV https://t.co/d9ZQVxbupc ...

🎉BitMart is thrilled to announce the listing of Rain (RAIN) @Rain__Protocol💰Trading pair: RAIN/USDT💎Deposit: 10/16/2025 4:00 AM UTC💎Trading: 10/16/2025 11:00 AM UTC🔥Register Now: https://t.co/pc8zxVsQei🔥Learn more: https://t.co/P18fXCLb7N#BitMart #RAIN #Crypto https://t.co/wukKk7abSK ...